Drugs / BL3000
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT04880889 | Jan → Jul 2023 | telogen effluvium | Biolab Sanus Farmaceutica | Unknown | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | BL3000 | “Research product: BL3000.” NCT04880889 ↗ |